News

Insights on the Convertible Debentures of DIAGNOS Inc.

Insights on the Convertible Debentures of DIAGNOS Inc.

Understanding the Amendment to Convertible Debentures

Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A) is at the forefront of utilizing Artificial Intelligence (AI) to enhance the early detection of specific ophthalmic health issues. Recently, DIAGNOS has provided essential updates regarding its convertible debentures, initially announced on February 28, 2025.

Key Information on Insider Ownership

Mr. André Larente, a notable insider and beneficial owner, holds two convertible debentures subject to an amendment, amounting to a total value of $20,000. If these debentures are converted and combined with his other outstanding securities, Mr. Larente could possess a total of 2,188,115 Common Shares in the Corporation, which translates to 2.15% of the company’s issued Common Shares on a partially diluted basis.

Understanding Related Party Transactions

Mr. Larente is classified as a “related party” as per the guidelines laid out in the Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions (“MI 61-101”). The transformation of the convertible debentures is exempt from certain requirements stipulated in MI 61-101 due to the fair market value of his participation in the amendments being less than 25% of DIAGNOS’s current market capitalization.

Approval Process and Conditions

To ensure that the best interests of DIAGNOS and its shareholders are considered, the board of directors has thoroughly reviewed and sanctioned the amendment to the convertible debentures. However, it remains important to note that this amendment is pending acceptance from the TSX Venture Exchange and requires the formal execution of documentation.

Financial Transactions and Market Practices

All financial figures mentioned in this communication are expressed in lawful Canadian currency. This kind of financial clarity is crucial for investors and stakeholders who are interested in the operations of DIAGNOS and its future directions.

About DIAGNOS Inc.

DIAGNOS is a publicly traded entity focused on the early identification of critical eye health issues, utilizing cutting-edge AI technology. The mission of DIAGNOS is to equip healthcare professionals with enhanced diagnostic tools, thereby improving patient care and outcomes globally.

Discover More About Our Services

For those wishing to explore more about DIAGNOS and its advancements in ophthalmic health, you can find additional information on their official website at www.diagnos.com or via www.sedarplus.com.

Frequently Asked Questions

What is DIAGNOS known for?

DIAGNOS specializes in the early detection of ophthalmic health problems using AI technology.

What recent updates have been made regarding the convertible debentures?

The company announced amendments and provisions involving insider ownership and approvals.

Who is André Larente?

He is an insider of DIAGNOS and owns convertible debentures that are being amended.

What is MI 61-101?

It’s a regulation aimed at protecting minority security holders in special transactions in Canada.

Where can I find more information about DIAGNOS?

Visit their website at www.diagnos.com for updates and detailed information.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Lupin Grabs FDA Nod: What Investors Should Know

Updated Category News Views 15

Lupin's Big Break Let's cut right to the chase: Lupin's latest FDA approval is no small potatoes. It's like getting a golden ticket in the pharma world, especially when you've been in the trenches as long as they have. As the first-to-file for their Amifampridine Tablets, 10 mg, this Indian giant is snagging that sweet 180-day exclusivity window. And in the cutthroat...

Continue Reading
ADC Therapeutics Preps Financial Results Release

Updated Category News Views 52

ADC Therapeutics: Eyes on the Financial Prize So here we are, folks—ADC Therapeutics is blitzing the stage and gearing up to spill the beans on their third-quarter saga come November 9, 2026. Who needs a crystal ball when you've got a press release to dissect every number and nuance? Anticipating the Numbers: What's at Stake? ADC Therapeutics has been riding the wave of...

Continue Reading
Northwood's $375M Boost: Satellite Network Expansion

Updated Category News Views 109

Northwood's Bold Leap into Space Connectivity Here's a nugget of info that could jolt your morning coffee: Northwood Space Corp—yeah, the folks linking satellites to Earth—just pulled in a whopping $375 million in Series C funding. This ain't your average capital injection; it's a full-throttle push to broaden their ground network reach and revamp space...

Continue Reading
JobPlanner Boosts Tools to Shield Margins in Construction

Updated Category News Views 80

Real-Time Solutions for Real-World Challenges JobPlanner is stepping up its game with some beefed-up financial management tools, and I gotta admit, it's like a lifeline in the raging sea of construction costs. We're talking about a souped-up Real-Time Job Costing Suite tailored for general and specialty contractors who are tired of watching their profits evaporate into...

Continue Reading
Atlas Power Expands with Boyland Electric Acquisition

Updated Category News Views 92

The Strategy Behind Atlas Power's Expansion Atlas Power Partners, no stranger to sizzling ambitions, has galvanized its portfolio by roping in Boyland Electric. This latest maneuver unfolds as Atlas hustles to become the go-to network for residential generator services. It’s a clear bet on 'quality over flair'—an ethos echoed by their CEO, David Fischer, who champions...

Continue Reading
First FedRAMP® 20x Class C Certification Earned

Updated Category News Views 36

Shifting Landscapes in Cybersecurity Certifications Change is the only constant in tech, and 360 Advanced sure knows how to ride that wave by leaping into the murky waters of FedRAMP's newest class. They’ve stamped their name on this historic FedRAMP® 20x Class C Certification by playing the role of the independent assessor for Perplexity's cloud service—a first...

Continue Reading
Vanity Fair Lingerie Reveals New Smoothing Bra

Updated Category News Views 53

A Bra Revolution or Just Another Launch? I'll admit it, lingerie isn't the usual breakfast discussion for me, but Vanity Fair Lingerie's move with their new Flawlessly Smooth™ Bra piqued my interest. Announced in Bowling Green, Kentucky, on November 2, 2026, and set against the lavish backdrop of an upcoming New York City event cohosted by Cosmopolitan, it's less about...

Continue Reading
Endeavor & GoPath's Game-Changing Cancer Test Launch

Updated Category News Views 88

Breaking Ground in Prostate Cancer Testing Just when you thought the medical field couldn't shake things up further, Endeavor Health and GoPath Diagnostics swoop in with a new genetic test for prostate cancer. This ain't just any run-of-the-mill test—it's the first of its kind to hit the clinical scene. The focus here is on sorting out which men with prostate cancer are...

Continue Reading
Xylitol: A Game Changer in Kids' Oral Care Battle

Updated Category News Views 56

Candy Challenges: Embracing Sweet Joys Responsibly Think you're done with Halloween? Nope. Welcome to the endless candy seasons when every festivity seems like an outlet for sugar overload—with parents caught between letting kids enjoy and guarding their teeth. Now, with Spry's recent push around xylitol, there's an option that might just mean an easier peace between...

Continue Reading
Wet Noses Innovates Human-Grade Pet Food at PLMA 2026

Updated Category News Views 59

Pet Food Revolution? Wet Noses Takes the PLMA Stage Okay, listen up, pet lovers and industry folks alike—seems like Wet Noses, that Washington-based veteran in the dog treat game, is shaking up the pet food world. After cruising through the pet aisle for almost three decades, they're making a splash at the PLMA 2026. Why should we care? Well, they’re pushing this...

Continue Reading

Top 5 Most Recently Viewed Articles

Old National Bancorp Welcomes Matt Keen as New CIO

Updated Category News Views 353

Old National Bancorp Appoints New Chief Information Officer Old National Bancorp has announced the appointment of Matt Keen as its Chief Information Officer (CIO). Keen joins the bank's Executive Leadership Team and will significantly influence the company’s technology direction and strategy. A Veteran Leader in Technology With a remarkable career spanning over three...

Continue Reading
Aquis Exchange Announces Key Trading Information Update

Updated Category News Views 233

Aquis Exchange's Essential Trading Disclosure Aquis Exchange plc recently made vital trading disclosures under the exemption provisions of the takeover code. This information is crucial for stakeholders and investors interested in understanding the current trading landscape. The company's engagement with principal traders and their recognized intermediary status...

Continue Reading
Gerber Collision & Glass Partners with Mitchell for Appraisal Tech

Updated Category News Views 149

Gerber Collision & Glass Enhances Repair Process with New Agreement In a significant move for the collision repair industry, Gerber Collision & Glass has announced a new partnership with Mitchell, a frontrunner in auto physical damage technology solutions. This groundbreaking agreement aims to streamline and optimize the collision-damage appraisal process, benefiting both...

Continue Reading
Future Growth of Remote Working Software Market to $127.8 Billion

Updated Category News Views 192

Overview of the Remote Working Software Market The remote working software market is on an impressive growth trajectory, with expectations to reach a value of $127.8 billion by 2033. This growth represents a significant increase from the current valuation of $23.2 billion in 2023, reflecting a robust compound annual growth rate (CAGR) of 17.8% from 2024 to 2033. As...

Continue Reading
Sunflower Bank, N.A. Invests Over $132,000 in Education for Youth

Updated Category News Views 71

Sunflower Bank's Commitment to Education Sunflower Bank, N.A. has taken a significant step in supporting education, contributing a generous total of $132,090 to K-12 schools and students as part of its ABC Program for Education. This investment includes $103,590 directed to participating schools for the 2023-2024 academic year, alongside $28,500 in rewards distributed to...

Continue Reading